Lesson plan
Itameline
Itameline ( ; developmental code name RU-47213) is a non-selective muscarinic acetylcholine receptor agonist nootropic drug which was under development for the treatment of Alzheimer's disease and memory disorders but was never marketed. Itameline is a prodrug of an arecoline derivative. It is an agonist of the muscarinic acetylcholine M 1 receptor as well as of other muscarinic acetylcholine receptors. Itameline is described as being superior to arecoline in terms of potency, central selectivity, and duration of action. The drug shows antiamnesic effects in animals, for instance reversing scopolamine-induced memory deficits. Structurally, it is a tetrahydropyridine similarly to xanomeline and milameline. Itameline was first described in the scientific literature by 1992. It was under development by Hoechst Marion Roussel and reached phase 2 clinical trials by 1998 prior to discontinuation of development.
Article summary
Itameline ( ; developmental code name RU-47213) is a non-selective muscarinic acetylcholine receptor agonist nootropic drug which was under development for the treatment of Alzheimer's disease and memory disorders but was never marketed. Itameline is a prodrug of an arecoline derivative. It is an agonist of the muscarinic acetylcholine M 1 receptor as well as of other muscarinic acetylcholine receptors. Itameline is described as being superior to arecoline in terms of potency, central selectivity, and duration of action. The drug shows antiamnesic effects in animals, for instance reversing scopolamine-induced memory deficits. Structurally, it is a tetrahydropyridine similarly to xanomeline and milameline. Itameline was first described in the scientific literature by 1992. It was under development by Hoechst Marion Roussel and reached phase 2 clinical trials by 1998 prior to discontinuation of development.
Key claims
No claims recorded.
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
No sources recorded.
Key claims and bibliography are generated from the same tracked claims and sources as the article page.